A new classification of coronary congenital diseases is set to help surgeons identify secondary defects in the operating theatre. The scheme is outlined in a novel European Society of Cardiology (ESC) position paper published ...
Jan 10, 2016
0
5
A new study has revealed stroke patients receiving emergency clot busting drugs, the correct dose of which depends on the patient's weight, may be receiving the wrong dose because the UK (and much of Europe) does not weigh ...
Nov 11, 2015
0
3
Before returning home to pursue her PhD in sociology at UC San Francisco, Rashon Lane had one last mission across the globe: go to Africa to help understand the Ebola epidemic.
Sep 24, 2015
0
9
Randomised controlled trials must be simplified to sustain innovation in cardiovascular diseases, which are still the biggest killer in Europe, according to the Cardiovascular Round Table (CRT).
Jun 15, 2015
0
15
Researchers from the Gladstone Institutes have used human cells to discover how blood flow in the heart protects against the hardening of valves in cardiovascular disease. What's more, they've identified a potential way to ...
Mar 12, 2015
0
13
Victoria University of Wellington research has identified reasons why a significant portion of heart attack patients do not respond to commonly used treatments.
Dec 8, 2014
0
0
Australia's largest clinical trial is a step closer to revealing in 2018 whether healthy older people should or should not take aspirin to prevent or delay cardiovascular disease (heart attack and stroke), dementia, depression ...
Dec 2, 2014
0
0
Epidemiologists know that an important piece of evidence is often staring you in the face – but it's not always easy to see the forest for the trees.
Jun 24, 2014
0
0
Researchers from the University of Copenhagen and the Technical University of Denmark have followed six million Danes for 15 years through patient and disease registers. Studies in the complex data landscape now enable researchers ...
Jun 24, 2014
0
0
Among patients with diabetes who were receiving metformin, the addition of insulin compared with a sulfonylurea (a class of antidiabetic drugs) was associated with an increased risk of nonfatal cardiovascular outcomes and ...
Jun 10, 2014
0
1
